Duration of Effective Antibody Levels After COVID-19

Pediatrics. 2021 Sep;148(3):e2021052589. doi: 10.1542/peds.2021-052589. Epub 2021 Jun 22.

Authors

Andrea T Cruz¹, Steven L Zeichner²

Affiliations

¹ Department of Pediatrics, Baylor College of Medicine, Houston, Texas acruz@bcm.edu.
² Departments of Pediatrics and Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, Virginia.

PMID: 34158313
DOI: 10.1542/peds.2021-052589

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Viral
COVID-19*
Humans
Immunoglobulin G
SARS-CoV-2

Substances

Antibodies, Viral
Immunoglobulin G